Science Explorer Back to mapMap
Discussion
Company · San Diego · United States

Vical (United States)

World rank, all time
#34,758
of 34,923
Rank in United States
#7,278
of 7,310
Research works
128
▼ 100% vs 2018-21
Citations
13k
100.0 per fractional work
Top-10% rate
15.6%
all institutions 10.0%
vs its own fields
1.12×
1.00× is exactly expected
Open access
22%
world 40%
International
7%
world 18%

Which fields of science does Vical (United States) work in?

In all years, 70% of research at Vical (United States) is in Life Sciences, 25% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (48%), Medicine (25%), Immunology and Microbiology (18%). It does 4.2× the world's share of Life Sciences.

Life Sciences: 89 fractional works · 69.9% of its workBiochemistry, Genetics and Molecular Biology: 62 fractional works · 48.2% of its workMolecular Biology: 42 fractional works · 32.6% of its workGenetics: 14 fractional works · 10.9% of its workBiotechnology: 4 fractional works · 3.3% of its workBiophysics: 0 fractional works · 0.4% of its workEndocrinology: 0 fractional works · 0.4% of its workCancer Research: 0 fractional works · 0.3% of its workMolecular Medicine: 0 fractional works · 0.3% of its workImmunology and Microbiology: 23 fractional works · 17.8% of its workImmunology: 19 fractional works · 14.8% of its workVirology: 3 fractional works · 2.6% of its workParasitology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workAgricultural and Biological Sciences: 3 fractional works · 2.1% of its workPlant Science: 1 fractional works · 1.0% of its workAnimal Science and Zoology: 1 fractional works · 0.4% of its workAgronomy and Crop Science: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.3% of its workNeuroscience: 1 fractional works · 1.0% of its workCellular and Molecular Neuroscience: 1 fractional works · 0.6% of its workDevelopmental Neuroscience: 0 fractional works · 0.4% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 0.7% of its workPharmaceutical Science: 1 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.1% of its workHealth Sciences: 32 fractional works · 24.9% of its workMedicine: 32 fractional works · 24.8% of its workEpidemiology: 10 fractional works · 7.7% of its workInfectious Diseases: 9 fractional works · 6.8% of its workPublic Health, Environmental and Occupational Health: 5 fractional works · 4.2% of its workOncology: 3 fractional works · 2.3% of its workRadiology, Nuclear Medicine and Imaging: 2 fractional works · 1.3% of its workSurgery: 1 fractional works · 0.4% of its workHematology: 0 fractional works · 0.3% of its workPhysiology: 0 fractional works · 0.3% of its workHepatology: 0 fractional works · 0.3% of its workPulmonary and Respiratory Medicine: 0 fractional works · 0.3% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.2% of its workSmaller subfields together: 1 fractional works · 0.6% of its workVeterinary: 0 fractional works · 0.1% of its workNursing: 0 fractional works · 0.0% of its workPhysical Sciences: 6 fractional works · 4.9% of its workEnvironmental Science: 3 fractional works · 2.3% of its workEcology: 3 fractional works · 2.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEngineering: 1 fractional works · 0.9% of its workBiomedical Engineering: 1 fractional works · 0.9% of its workMaterials Science: 1 fractional works · 0.7% of its workBiomaterials: 1 fractional works · 0.7% of its workChemistry: 1 fractional works · 0.5% of its workOrganic Chemistry: 1 fractional works · 0.5% of its workChemical Engineering: 0 fractional works · 0.3% of its workChemical Health and Safety: 0 fractional works · 0.3% of its workMathematics: 0 fractional works · 0.1% of its workComputer Science: 0 fractional works · 0.1% of its workSocial Sciences: 0 fractional works · 0.3% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.3% of its workEconomics and Econometrics: 0 fractional works · 0.3% of its workALL ITS WORKVical (UnitedStates)128fractional works, all years
Life Sciences70%Physical Sciences5%Health Sciences25%Social Sciences0%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 16 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology6248.2%
    2. Immunology and Microbiology2317.8%
    3. Agricultural and Biological Sciences32.1%
    4. Neuroscience11.0%
    5. Pharmacology, Toxicology and Pharmaceutics10.7%
    1. Medicine3224.8%
    2. Veterinary00.1%
    3. Nursing00.0%
    1. Environmental Science32.3%
    2. Engineering10.9%
    3. Materials Science10.7%
    4. Chemistry10.5%
    5. Chemical Engineering00.3%
    6. Mathematics00.1%
    7. Computer Science00.1%
    1. Economics, Econometrics and Finance00.3%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What does Vical (United States) specialise in?

Where its research is concentrated relative to its size: Immunology and Microbiology takes 14.6× the share of its output that it takes of world research.

  1. Immunology and MicrobiologyField · 22.8 works15×
  2. Molecular BiologySubfield · 41.6 works8.2×
  3. Biochemistry, Genetics and Molecular BiologyField · 61.6 works7.0×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

    Who are the top researchers at Vical (United States)?

    Ranked on the quality score, Suezanne E. Parker, Peter M. Hobart and Jon A. Norman lead among researchers whose main affiliation is Vical (United States).

    1. 1 Suezanne E. Parker United States · #237,742 worldwide 6.3k citations · 55 works
    2. 2 Peter M. Hobart United States · #429,740 worldwide 6k citations · 63 works
    3. 3 Jon A. Norman United States · #1,007,463 worldwide 4.9k citations · 70 works
    4. 4 Jukka Hartikka United States · #1,121,664 worldwide 4.9k citations · 50 works
    5. 5 Holly M. Horton United States · #1,261,439 worldwide 2.6k citations · 89 works
    6. 6 Ya-Li Tsai United States · #1,976,302 worldwide 2.4k citations · 22 works
    7. 7 Carl J. Wheeler United States · #2,022,200 worldwide 2k citations · 32 works
    8. 8 Kerry M. Barnhart United States · #2,075,319 worldwide 2.2k citations · 49 works
    9. 9 Xiaolan Liang United States · #2,160,728 worldwide 972 citations · 22 works
    10. 10 Marilyn E. Ferrari United States · #3,112,107 worldwide 2k citations · 23 works
    All ranked researchers at Vical (United States)

    What are the most cited papers from Vical (United States)?

    The most cited paper from Vical (United States) is "Direct Gene Transfer into Mouse Muscle in Vivo" (Jon A. Wolff, Robert W. Malone, Phillip A. Williams et al., 1990), with 4,189 citations. Next come "Heterologous Protection Against Influenza by Injection of DNA Encoding a Viral Protein" (2,326) and "Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations." (1,315).

    Most cited papers
    #PaperReleasedCitations
    1 Direct Gene Transfer into Mouse Muscle in Vivo Jon A. Wolff, Robert W. Malone, Phillip A. Williams et al. · Science 23 Mar 1990 4,189
    2 Heterologous Protection Against Influenza by Injection of DNA Encoding a Viral Protein Jeffrey B. Ulmer, John Donnelly, Suezanne E. Parker et al. · Science 19 Mar 1993 2,326
    3 Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. Jiin H. Felgner, Rajesh Kumar, Ch. Sridhar et al. · Journal of Biological Chemistry Open access 1994 1,315
    4 Cationic liposome-mediated transfection Philip Louis Felgner, GORDON M. RINGOLD · Nature 1989 990
    5 An Improved Plasmid DNA Expression Vector for Direct Injection into Skeletal Muscle Jukka Hartikka, Michael Sawdey, Francine Cornefert-Jensen et al. · Human Gene Therapy Jul 1996 335
    All 60 most cited papers, with filters and sorting

    Which keywords describe research at Vical (United States)?

    By fractional works in all years, weighted toward what it does more of than the world: Gene Therapy, RNA Interference, siRNA Delivery, Antigen Presentation, Cancer Immunotherapy, Epidemiology, Innate Immunity and Genomic Integration.

    ▲ more of its work than of the world's◆ about the world's share▼ less than the world's

    Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

    All 40 words, with their numbers
    1. Gene Therapy35▲ 104×4 topics
    2. RNA Interference21▲ 143×1 topic
    3. siRNA Delivery21▲ 213×1 topic
    4. Epidemiology19▲ 3.6×22 topics
    5. Antigen Presentation14▲ 111×2 topics
    6. Cancer Immunotherapy13▲ 74×2 topics
    7. Innate Immunity13▲ 28×6 topics
    8. Genomic Integration12▲ 94×2 topics
    9. Immunity12▲ 28×4 topics
    10. Pathogenesis12▲ 16×7 topics
    11. Dendritic Cells12▲ 78×1 topic
    12. Tumor Antigen12▲ 111×1 topic
    13. Vaccine12▲ 23×9 topics
    14. AAV12▲ 139×1 topic
    15. Viral Vectors12▲ 139×1 topic
    16. Nanoparticles10▲ 5.8×4 topics
    17. Immune Response8▲ 10×9 topics
    18. Vaccine Development8▲ 21×5 topics
    19. Infection7▲ 20×2 topics
    20. Genomics6▲ 14×4 topics
    21. Virus6▲ 40×3 topics
    22. DNA nanotechnology6▲ 44×1 topic
    23. Self-Assembly6▲ 11×1 topic
    24. Antibodies5▲ 46×2 topics
    25. Norovirus4▲ 56×1 topic
    26. Rotavirus4▲ 56×1 topic
    27. Antiviral Therapy4▲ 20×3 topics
    28. Glycosylation4▲ 13×2 topics
    29. Immune Evasion4▲ 50×2 topics
    30. Pandemic4▲ 6.1×2 topics
    31. Tumor Regression4▲ 31×2 topics
    32. Metagenomics3▲ 21×2 topics
    33. Antiretroviral Therapy3▲ 11×2 topics
    34. Biopharmaceutical Production3▲ 32×2 topics
    35. Pattern Recognition Receptors3▲ 17×3 topics
    36. Cell Culture3▲ 22×2 topics
    37. Cytomegalovirus3▲ 50×1 topic
    38. Evolution3▲ 8.0×2 topics
    39. Genome Engineering3▲ 41×1 topic
    40. RNA-Guided3▲ 41×1 topic

    Which research topics does Vical (United States) publish most on?

    By volume: RNA Interference and Gene Delivery, Immunotherapy and Immune Responses, Virus-based gene therapy research and Advanced biosensing and bioanalysis techniques.

    1. 1 RNA Interference and Gene Delivery Molecular Biology 21 works
    2. 2 Immunotherapy and Immune Responses Immunology 12 works
    3. 3 Virus-based gene therapy research Genetics 12 works
    4. 4 Advanced biosensing and bioanalysis techniques Molecular Biology 6 works
    5. 5 Viral gastroenteritis research and epidemiology Infectious Diseases 4 works
    6. 6 Cytomegalovirus and herpesvirus research Epidemiology 3 works
    7. 7 CRISPR and Genetic Engineering Molecular Biology 3 works
    8. 8 Influenza Virus Research Studies Epidemiology 3 works
    9. 9 Bacteriophages and microbial interactions Ecology 3 works
    10. 10 vaccines and immunoinformatics approaches Molecular Biology 3 works

    How open and international is its research?

    Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

    openly available22.2%not open77.8%

    World: 40% of research is openly available.

    with international co-authors7.3%domestic only92.7%

    World: 18% is written across borders.

    How has Vical (United States)'s research output changed?

    Output in 2022-2025 was 100% lower than in 2018-2021.

    1990200020102020
    grewheldshrank

    The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

    Its share of all research

    Growing output can still be a shrinking share: all of science grows. This is Vical (United States) as a percentage of every work published that year, 0.0000035% in 2020.

    0.00050%0.0010%0.0015%Vical (United States)0.00000078% in 20211990200020102020

    Fractional works of Vical (United States) over all fractional works that year. How the balance of science has shifted.

    Other research institutions in San Diego

    All research institutions in San Diego

    Share Vical (United States)'s ranking

    Vical (United States) on Science Explorer

    A card with Vical (United States)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

    Download the card

    1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

    Badges for a website1Each links back here and updates with every snapshot

    Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

    Discussion

    Ask a question or share a note about Vical (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.